GENEVA, March 24 -- GMP BIOTECHNOLOGY LIMITED (Unit 2212, 22/F, CC Wu Building302-308 Hennessy Road WanchaiHong Kong, Hong Kong), TRIEU, Vuong (29397 Agoura Road, Suite 107Agoura Hills, California 91301) filed a patent application (PCT/US2025/045662) for "TGFB2 THERAPEUTICS FOR CANCER WITH SURVIVAL MARKERS" on Sep 10, 2025. With publication no. WO/2026/059948, the details related to the patent application was published on Mar 19, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): GMP BIOTECHNOLOGY LIMITED (Unit 2212, 22/F, CC Wu Building302-308 Hennessy Road WanchaiHong Kong, Hong Kong), TRIEU,...